You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

phase 1/2a

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))

Recruiting
  • Duchenne Muscular Dystrophy
  • Phase 1, SQY51
  • +3 more
  • Garches, France
    Hôpital Raymond Poincaré
Mar 7, 2023

Acquired Blepharoptosis Trial (LEV102 1.0%, LEV102 2.0%, Vehicle)

Not yet recruiting
  • Acquired Blepharoptosis
  • LEV102 1.0%
  • +2 more
  • (no location specified)
Feb 6, 2023

Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)

Not yet recruiting
  • Myotonic Dystrophy 1
  • ARO-DM1 for Injection
  • Placebo
  • (no location specified)
Nov 14, 2023

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

Recruiting
  • Solid Tumor
  • +2 more
  • Haifa, Israel
  • +2 more
Oct 12, 2022

Pancreatic Cancer Trial (PBP1510 (400mg/16mL), Gemcitabine (1000 mg/m^2))

Not yet recruiting
  • Pancreatic Cancer
  • PBP1510 (400mg/16mL)
  • Gemcitabine (1000 mg/m^2)
  • (no location specified)
Sep 27, 2022

Altitude Edema Trial (Advair HFA, Placebo)

Not yet recruiting
  • Altitude Edema
  • Advair HFA
  • Placebo
  • (no location specified)
Sep 8, 2023

Glioblastoma Trial (RZ-001, VGCV)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Oct 22, 2023

Advanced Solid Tumors Trial in Plantation (DB-1311)

Not yet recruiting
  • Advanced Solid Tumors
  • Plantation, Florida
    BRCR Medical Center Inc.
Jun 13, 2023

Open-angle Glaucoma Trial in Indianapolis (PER-001 Intravitreal Implant - Low Dose, PER-001 Intravitreal Implant - High Dose,

Recruiting
  • Open-angle Glaucoma
  • PER-001 Intravitreal Implant - Low Dose
  • +2 more
  • Indianapolis, Indiana
    MidWest Eye Institute
Apr 25, 2023

Non-muscle-invasive Bladder Cancer Trial (STM-416)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Jan 25, 2023

Diabetic Foot, Diabetic Foot Ulcer, Diabetic Foot Ulcer Neuropathic Trial in Jerusalem (hOMSC200, Placebo)

Recruiting
  • Diabetic Foot
  • +2 more
  • hOMSC200
  • Placebo
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Aug 15, 2023

Solid Tumor, Unspecified, Adult Trial in Taipei (MPB-1734)

Recruiting
  • Solid Tumor, Unspecified, Adult
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Apr 27, 2022

Advanced Solid Tumor Trial in Fairfax, Shanghai (DB-1310)

Not yet recruiting
  • Advanced Solid Tumor
  • Fairfax, Virginia
  • +1 more
Mar 29, 2023

Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)

Not yet recruiting
  • Facio-Scapulo-Humeral Dystrophy
  • ARO-DUX4 for Injection
  • Placebo
  • (no location specified)
Nov 13, 2023

Vancomycin-Resistant Enterococcal Colonization Trial (VRELysin™, Placebo)

Not yet recruiting
  • Vancomycin-Resistant Enterococcal Colonization
  • VRELysin™
  • Placebo
  • (no location specified)
Jan 27, 2023

Alzheimer Trial (ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo)

Not yet recruiting
  • Alzheimer Disease
  • ALZN002 (autologous DCs pulsed with E22W mutant peptide).
  • Placebo
  • (no location specified)
Apr 17, 2023

LGMD Trial (GenPHSat injection (Safety), GenPHSat injection (Efficacy), Muscle Biopsy (Safety))

Not yet recruiting
  • LGMD
  • GenPHSat injection (Safety)
  • +2 more
  • (no location specified)
Oct 20, 2022

Dentin Sensitivity Trial in Seoul (KH001, Placebo)

Recruiting
  • Dentin Sensitivity
  • Seoul, Korea, Republic of
    Seoul National University Dental Hospital
Oct 13, 2022

AL Amyloidosis, Amyloidosis Trial in Stanford, Boston, Rochester (Belantamab mafodotin 2.5 mg/kg (6 weeks), Belantamab mafodotin

Not yet recruiting
  • AL Amyloidosis
  • Amyloidosis
  • Belantamab mafodotin 2.5 mg/kg (6 weeks)
  • +4 more
  • Stanford, California
  • +3 more
Jul 25, 2022

Advanced Solid Tumor Trial in São Paulo, Santo André (IMX-110 combined with Tislelizumab)

Recruiting
  • Advanced Solid Tumor
  • IMX-110 combined with Tislelizumab
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Apr 28, 2023

Prion Disease Trial (ION717, Placebo)

Not yet recruiting
  • Prion Disease
  • (no location specified)
Nov 29, 2023

Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)

Recruiting
  • Glioblastoma Multiforme
  • Perillyl alcohol
  • Los Angeles, California
  • +1 more
Sep 23, 2022

Multiple System Atrophy, MSA - Multiple System Atrophy Trial in Tel Aviv (hOMSC300, Sham Procedure)

Recruiting
  • Multiple System Atrophy
  • MSA - Multiple System Atrophy
  • Tel Aviv, Israel
    Tel-Aviv Sourasky Medical Center (Ichilov)
Jan 24, 2023

Advanced Solid Tumors Trial in Australia, Korea, Republic of, Thailand (YBL-006)

Active, not recruiting
  • Advanced Solid Tumors
  • Macquarie, New South Wales, Australia
  • +6 more
Dec 1, 2022